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Dear Sir,
Cutaneous malignant melanoma incidence has more
than doubled over the past 25 yrs, and this trend contin-
ues across all age groups at a rate of over 3% per yr
(Linos et al., 2009). Exposure to the ultraviolet (UV)
portion of sunlight is strongly implicated in melanoma
etiology and considered the major environmental risk
factor. Higher melanoma risk is associated with burning
UV doses, both intermittent and during childhood (Gan-
dini et al., 2005). Alarmingly, melanomas are the most
prevalent cancer in 25–29 yr old females, and a link to
commercial tanning sunlamps use is suggested (Purdue
et al., 2008). Melanoma prevention recommendations
include avoiding mid-day sun and artiﬁcial UV light,
wearing protective clothing and hats, and using sun-
screen with a Sun Protective Factor (SPF) of 15 or
higher (American Cancer Society, 2010). However, the
SPF sunscreen rating describes erythema or sunburn
protection; sunscreens are not rated for the prevention
of melanoma or other skin cancers (FDA, 1999). Mela-
noma incidence reduction through sunscreen use has
not yet been proven, and in fact has been controversial
(Saraiya et al., 2003). We here present data that demon-
strate for the ﬁrst time signiﬁcant sunscreen prevention
in UV-dependent, melanoma-prone transgenic mice, and
propose that when applied properly should be preven-
tive in people.
Human epidemiologic studies of melanoma preven-
tion are limited by recall bias, insufﬁcient statistical
power, and non-uniform estimations of sun exposure
and sunscreen use. Therefore, sunscreen use and mela-
noma risk reduction or mortality prevention are difﬁcult
to accurately assess and remain inconclusive (Bastuji-
Garin and Diepgen, 2002; Saraiya et al., 2003). We eval-
uated sunscreen use as a risk factor for melanoma in a
large case-control study with 717 non-Hispanic white,
invasive melanoma patients and 945 matched controls
(Fears et al., 2002). The univariate analyses of ever sun-
screen use or regular use of sunscreen of SPF ‡ 8 indi-
cated minimal risk associated with sunscreen use
(relative odds 1.05 and 1.11, respectively). This associa-
tion is suggested to reﬂect users’ sun sensitivity (burn-
ing and tanning tendencies), and not a property
of sunscreen exposure per se (Dennis et al., 2003).
A matched logistic regression analysis of sunscreen use
adjusted for average UVB intensity of residences, adult
hours outdoors, tan-type, number sunburns, age-group,
study-site and gender (Appendix S1), showed that sun-
screen use was not associated with melanoma (OR
0.90, 95% CI 0.70–1.16; Table 1). When evaluating sun-
screen users and examining risk in those who burned
easily and persons who did not burn in a single model,
the relative odds for those who burned easily decreased
slightly to 0.85 (0.62–1.19) and for those who did not
burn was 0.91 (0.70–1.19) with no statistically signiﬁ-
cant difference in risks (Table 1). The changes in risks
observed after appropriate adjustment likely reﬂect
confounding, a spurious relationship, as persons using
sunscreens may be more susceptible to melanoma.
These data demonstrate the challenges of assessing
complex behaviors, such as sunscreen use, outside of a
prospective randomized study. Even in our large investi-
gation, difﬁculty in addressing these challenges illus-
trates the urgent need for appropriate animal models,
employed experimentally, to better assess the value of
sunscreen use in melanoma prevention.
TheavailabilityoftheHepatocyteGrowthFactor⁄Scatter
Factor (HGF⁄SF) genetically engineered mouse, which
develops neonatal UV-dependent skin lesions highly
reminiscent of cutaneous malignant melanoma (Noonan
et al., 2001), provides a favorable platform to demon-
strate experimentally the capabilities of sunscreen in a
melanoma prevention study. This mouse model has
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constitutes a major melanoma risk factor (Noonan et al.,
2001). Therefore, we hypothesized that blocking UV
radiation-induced erythema with current dermatologist
recommended SPF15 sunscreen would signiﬁcantly
decrease the incidence of melanoma in this relevant
murine melanoma model.
Neonatal mice were exposed to a single dose of
UV radiation with prior application (15 min) of either
vehicle-control lotion or SPF15 sunscreen containing
FDA-approved active agents (Appendix S1). The UV
dose corresponded to a human erythemally-weighted
UV dose of 2.3 kJ⁄m
2 or 23 Standard erythemal dose
units, equivalent to a sun-burning dose in people (Noo-
nan et al., 2001). The primary endpoint was melanoma
development in the dorsal application area, conﬁrmed
by histopathology and positivity for melanocytic anti-
gens. The SPF15 sunscreen-treated animals developed
signiﬁcantly fewer melanomas than the vehicle-control
group (P = 0.043; Figure 1). In the sunscreen-treated
group (n = 97), one mouse (1%) developed two dorsal
melanomas, while the eight mice (7%) in the vehicle-
control group (n = 118) developed 18 melanomas
(Figure 1; Table S1). The multiplicity of melanomas per
animal arising in the sunscreen-treated group was also
lower, with two per animal versus up to seven per
animal in the vehicle controls. Animals from both groups
equally developed melanoma outside of lotion-treated
Table 1. Melanoma in persons with no sunscreen use, and those
who used any sunscreen, among sunscreen users by tendency to
burn or sun sensitivity
Sunscreen use
Number of
controls
a
Number of
cases
b Total OR
c (95% CI)
No use 202 147 349 Referent
Ever use 743 570 1313 0.90 (0.70–1.19)
Total 945 717 1662
Burn easily 186 160 346 0.85 (0.62–1.19)
Do not burn 557 410 967 0.91 (0.70–1.19)
Total 743 570 1313
aPersons recruited from same geographical area as Cases, and
matched on age, sex, race.
bPersons with histologically conﬁrmed cutaneous malignant
melanoma diagnosis.
cAll OR adjusted for ambient residential UV intensity, number of
hours outdoors, tan type, number of sunburns, gender, age group,
and study site.
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Figure 1. UV-induced melanomas and UV-induced DNA damage
are signiﬁcantly inhibited in sunscreen-treated compared to vehicle
control-treated mice. Melanoma incidence per group and the
average ratio of TT-dimer-containing cells to no TT-dimer-containing
cells are presented as a percentage of control. Filled bars, vehicle
control-treated mice; open bars, SPF15-treated mice. The numbers
indicate the percentage of control for the SPF15 group incidence,
and for the SPF15 group TT-dimer ratio.
A
B
Figure 2. Sunscreen use decreases UV-induced DNA damage in
the skin of mice. Skin micrographs are representative of all those
observed; tissues were harvested at 7 min post-UV irradiation. (A)
Throughout the skin of a control lotion-treated animal, brown
nuclei, positive for anti-TT dimers, are found. The white arrow
highlights brown nuclei, and the area of the inset photo. (B) In skin
from a SPF15-treated animal, a typical area shows blue-grey nuclei
with no or few TT-dimers (white arrow; area of inset photo). A rare
patch of brown, anti-TT reactive nuclei is observed in the
epidermis⁄upper skin (yellow arrow). Scale bars in (A) and (B) are
50 micrometers. Scale bars in both (A) and (B) insets are 20
micrometers.
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The molecular mechanisms by which sun and artiﬁcial
UV light initiate and⁄or promote melanoma development
are being elucidated (Zaidi et al., 2008). Clearly, both
direct and⁄or indirect DNA damage mechanisms, includ-
ing thymine dimer and genotoxic reactive oxygen spe-
cies formation, may play a mechanistic role. We
therefore quantiﬁed DNA damage in skin cells of UV-
treated control and SPF15 sunscreen-treated animals
using an antibody to thymine-thymine (TT) dimers, a
type of damage initiated by UVB irradiation. Cells were
scored ‘positive’ if double-stained for TT dimers and
nuclear counter-stain at seven minutes post-UV. The
vehicle control lotion-treated skin averaged greater than
ﬁve cells with nuclear DNA damage to each non-DNA
damaged cell (Figure 2; Table S1). In sunscreen-treated
skin, the TT:no-TT ratio was <1, indicating a distinct sun-
screen protective effect in UV-exposed skin (P = 0.004;
Figure 2; Table S1). The UV-induced DNA damage in
vehicle control lotion-treated skin extended throughout
the length of the epidermis and into dermis and upper
hair follicle regions (Figure 2A and inset; anti-TT positive,
brown nuclei; white arrow). In contrast, only small
patches of DNA damage-containing cells (Figure 2B,
white arrow) were observed along the epidermis and
epidermal⁄dermal junction of SPF15 sunscreen-treated
animals (Figure 2B and inset; blue counter-stained
nuclei; yellow arrow). Thus, a sunscreen protective-
effect against UV-induced damage is observed in the
treated animals’ skin.
The major environmental risk factor for melanoma is
well established to be UV exposure. Further, cumulative
UV exposure, both in childhood and as adults, contrib-
utes to melanoma etiology and its’ expanding epidemic
(Lea et al., 2007; Linos et al., 2009; Tucker and Gold-
stein, 2003). We employed a relevant animal model of
cutaneous malignant melanoma to corroborate, for the
ﬁrst time, what present and previous epidemiological
data has only suggested but not proven: sunscreen use
can signiﬁcantly inhibit melanomagenesis. In addition,
we correlate sunscreen use in the same mouse model
with prevention of DNA damage in UV-irradiated skin.
Our data advance arguments for a public health strategy
to prevent melanoma and reduce mortality involving
sunscreen use, as well as UV-irradiation avoidance
behaviors and increased access to screening.
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online version of this article.
Table S1. Sunscreen use decreases UV-induced mel-
anoma development and DNA damage in HGF⁄SF trans-
genic mouse skin.
Appendix S1. Materials and Methods.
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